EGFR and cancer: Particularly, FGFs, an important family of polypeptides integral to pulmonary biology, contribute to functional heterogeneity within CAFs, influencing cancer progression and patient responses to treatments such as epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase tyrosine kinase inhibitors.36